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Abstract
Objective. To describe the Italian Obstetric Surveillance System (ItOSS) investigating 
maternal death through incident case reporting and confidential enquiries. 
Methods. All maternal deaths occurred in any public and private health facility in 8 
Italian regions covering 73% of national births have been notified to the ItOSS. Every 
incident case is confidentially reviewed to assess quality of care and establish the cause 
and avoidability of the death. 
Findings. A total of 106 maternal deaths among 1 455 545 live births have been notified 
to the surveillance system in 2013-17. Haemorrhage, sepsis and hypertensive disorders 
of pregnancy are the leading causes of direct maternal deaths due to obstetric causes. 
Conclusions. A maternal mortality surveillance system, including incidence reporting 
and confidential enquiries along with a retrospective analysis of administrative data 
sources, emerged as the best option for case ascertainment and for preventing avoidable 
maternal deaths. 
INTRODUCTION
Maternal mortality is acknowledged as a general in-
dicator of the overall health of a population, of the sta-
tus of women in society and of the quality of health 
systems. The inequities of the geographical distribution 
of maternal mortality in the world, and the evidences 
that marginalized, poor and vulnerable women are at 
higher risk of pregnancy-related death, make maternal 
death an intolerable injustice and impose to take ac-
tion [1]. The maternal mortality ratio (i.e. the number 
of maternal deaths per 100 000 live births, MMR) is the 
most widely used measure of maternal mortality [2]. 
The MMR is useful for advocacy purposes but it does 
not explain the real underlying reasons why particular 
women died and lacks information helping us identify 
what can be done to prevent or avoid such deaths [3]. 
A systematic multidisciplinary anonymous investiga-
tion of incident maternal deaths based on confidential 
enquiries is indeed required to understand the factors 
that led to the death and to put in place appropriate 
remedial actions [4]. Maternal mortality surveillance 
systems based on confidential enquiries provide the 
opportunity to describe the appropriateness of obstet-
ric care by identifying problems related to the quality 
of clinical practice and services organization [5]. They 
also support the identification of the training needs of 
health professionals and the definition of public health 
priorities in the area of maternal and newborn health. 
Surveillance, review and reporting are therefore a public 
health priority and in 2016 the World Health Organi-
zation (WHO) stated that all women deserve maternal 
death surveillance systems able to detect and properly 
investigate the causes and the critical aspects of care 
that can be improved [6].
At the international level approaches and methods to 
assess maternal mortality vary considerably [1, 7] with 
the UK maternal mortality surveillance system acknowl-
edged as a gold standard worldwide [5]. The emphasis 
on the link between information and response to move 
beyond the numbers of maternal deaths is well known 
in the approach to maternal mortality surveillance [3, 5, 
8] but it is not yet widespread. 
Starting from 2008, retrospective studies based on 
linkage procedures of multiple administrative data 
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sources conducted by the Italian National Institute 
of Health (ISS) repeatedly observed a 60% underes-
timation of the officially published Italian MMR [9, 
10]. The underestimation size raised concerns among 
the national scientific community and the policy mak-
ers, thereby paving the way for the setup of the Italian 
Obstetric Surveillance System (ItOSS) in 2013, which 
added a prospective maternal deaths surveillance sys-
tem based on confidential enquiries to the retrospective 
studies previously conducted to estimate the MMR. 
The population based prospective surveillance system 
aims at generating the information required to outline 
realistic and practical actions aimed to reduce prevent-
able maternal severe morbidity and mortality. Continu-
ous data collection, in depth analysis through clinical 
audits and confidential enquiry, as well as response by 
acting on ﬁndings actively promote a “no blame” cul-
ture in a country where obstetricians are often sadly 
influenced by a defensive medicine approach. The set 
up and the first three years of the prospective maternal 
death surveillance were funded by the Italian Ministry 
of Health. From 2017 a Decree of the President of the 
Council of the Italian Ministers attributes to the ISS 
the responsibility of the national coordination of the 
surveillance. 
This paper describes the methods and the main re-
sults for the first five years of incident reporting and 
confidential enquiries for maternal death surveillance 
coordinated by the ISS in collaboration with eight Ital-
ian Regions in the framework of the ItOSS.
MATERIALS AND METHODS
The prospective surveillance system considers inci-
dent cases of maternal death from direct obstetric or 
indirect non obstetric causes [11] of all women who 
died during pregnancy or up to 42 days after the end 
of pregnancy (spontaneous abortion, induced abortion, 
ectopic pregnancy, live birth or stillbirth). All public or 
private health facilities with an obstetric unit and/or an 
intensive care unit and/or a coronary care unit and/or a 
stroke unit in the participating regions are included in 
the surveillance network, according to the assumption 
that all maternal deaths are intercepted by at least one 
of these facilities. 
The eight Italian Regions included in the present 
study had been progressively enrolled taking into ac-
count the geographical area to which they belong and 
the annual number of births.
The ISS appointed a regional coordination unit 
(RCU) in each participating region. A reference per-
son – a motivated medical doctor or midwife – has been 
selected in every facility and a multidisciplinary regional 
expert committee (MREC) responsible for the confi-
dential enquiries has been put in place. Each MREC 
includes two obstetricians, two anesthesiologists, one 
midwife, one pathologist and one risk manager. Other 
medical specialists are involved when required. Every 
hospital reference person and a representative of the 
clinical risk management network for each facility re-
ceived a residential training on the operational aspects 
of the surveillance system and a training package for 
cascade teaching to all professionals involved in the 
women’s assistance in their obstetrics units. 
Figure 1 summarizes the various steps of the ItOSS 
prospective surveillance. Every maternal death is no-
tified from the facility where the death took place to 
the RCU, who is asked to inform the ISS central office 
and to verify the achievement of an internal audit in 
the health facility within one month of the death. The 
audit is facilitated by the risk manager of the hospital 
in collaboration with the reference person and involves 
all local staff who provided clinical care to the deceased 
woman. During the audit an anonymous form on the 
clinical history of the deceased woman is filled in by the 
participant clinicians. This form and the woman’s ano-
nymised medical records are delivered to the MREC 
for the confidential enquiry, which aims to assess the 
cause of death, the quality of care and the death avoid-
ability. The results of the enquiry and the complete 
documentation of the case are finally transferred to the 
ISS for a central review performed with the support of 
the experts of the national scientific committee and 
of medical specialists of recognized authority in other 
disciplines. If the assessment of the central review dif-
fer from those of the MREC, the anonymized case is 
jointly discussed by the central and the regional com-
mittees in order to reach a conclusive shared evalua-
tion. The whole system allows to describe each maternal 
death by cause, quality of care and avoidability. The lat-
ter are classified as: appropriate care with unavoidable 
outcome, improvable care with unavoidable outcome, 
inappropriate care with avoidable outcome. Based on 
the cases analysis, recommendations for clinical prac-
tice are produced and returned to health professionals. 
Detailed information on the organizational character-
istics of the obstetric units that notify maternal deaths 
are also collected and analysed. 
A record-linkage procedure between death registry 
and hospital discharge database is used to verify the 
completeness of the maternal deaths reporting to the 
prospective surveillance system. Cases retrieved in this 
way are considered only for the MMR estimation due 
to the lack of the in depth assessment.
The present study includes cases of maternal death 
Death notication within 48 hours 
Multiprofessional audit inside the health facility 
Condential enquiry by the multidisciplinary
regional experts committee 
Regional Coordination Unit 
Italian National Institute of Health
Central revision
• Review by the central scientic and technical committee
• Review of discordant cases  by central and regional experts committee
Dissemination of results, clinical recommendations, impact evaluation
Figure 1
The prospective surveillance system flow chart.
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notified or retrieved from 2013 to 2017. A descriptive 
analysis by sociodemographic characteristics, obstetric 
history and cause of death was performed. Quality of 
care, avoidability of the notified maternal deaths and 
the organizational characteristics of the obstetrics units 
where the women deceased were also assessed. 
All analyses were performed with STATA software, 
version 11 (Stata Corporation, College Station, Texas, 
USA). 
The surveillance activity was approved by the ethic 
committee of the INIH (Prot. PRE-C318/15, Rome 
12/05/2015).
RESULTS
Maternal deaths and participating Regions
The prospective maternal mortality surveillance sys-
tem started on February 1, 2013 in 6 Italian regions 
covering 49% of the national births and distributed 
throughout the country (Piedmont, Emilia-Romagna, 
Tuscany, Lazio, Campania, and Sicily). Lombardy and 
Puglia regions have joined the system in July 1, 2015 
increasing its coverage to 73% of total new-borns. Dur-
ing the 5 years considered (2013-2017) the participant 
regions notified 114 cases of death. Five incidental 
deaths (1 car accident, 1 domestic accident, 1 homi-
cide and 2 non-hormone-dependent neoplasms) and 3 
deaths concerning non-resident migrant women were 
excluded from this analysis. Four more cases were iden-
tified through the record-linkage procedure. Therefore 
110 direct and indirect maternal deaths among 1 455 
545 new-borns [12] were counted, corresponding to a 
MMR of 7.56/100 000 live births (CI 95% 6.21-9.11). 
The 4 maternal deaths retrieved through the record-
linkage were excluded from the following descriptive 
analysis. 
Maternal sociodemographic and obstetric 
characteristics
Among 106 maternal deaths 50.5% women was ≥ 
35 years old, 25.5% didn’t have Italian citizenship with 
19 women coming from low income countries (Africa, 
Asia or South America) and 8 women from high income 
countries, 7 of them from Romania. The proportion of 
deceased women with BMI ≥ 30 kg/m2 was 20.8%. More 
than half of women (52.4%) was nulliparous, 12 mater-
nal deaths occurred in women who conceived through 
artificial reproductive technologies (ART) and the multi-
ple pregnancies were 10. Most deaths (75.5%) occurred 
during delivery, 30 were associated with an emergency 
caesarean section (CS), 17 with an urgent CS, 14 with 
an elective CS, 19 with a vaginal delivery and 5 with an 
operative vaginal delivery. Thirteen women died during 
pregnancy, 12 post abortion (7 miscarriages, 5 voluntary 
termination of pregnancy). One woman died as a conse-
quence of an ectopic pregnancy (Table 1).
Causes of death
The leading causes of the 106 direct and indirect ma-
ternal deaths were maternal sepsis (23 cases, 21.7%) 
and obstetric haemorrhages (22 cases, 20.8%), followed 
by hypertensive disorders of pregnancy (9 cases, 8.5%) 
and cardiovascular diseases (9 cases, 8.5%). Table 2 de-
scribes the causes of the maternal deaths notified to the 
surveillance system, divided into direct (n = 58) and in-
direct (n = 39). Nine deaths were not classifiable. 
Direct maternal deaths
Obstetric haemorrhage was responsible for 37.9% (n = 
22) of the direct deaths, 2 cases occurring during the 
Table 1
Sociodemographic and obstetric characteristics of the de-
ceased women
   Maternal deaths 
n = 106
Maternal age (3 missing) n %
< 35 years 51 49.5
≥ 35 years 52 50.5
Citizenship
Italian 79 74.5
Low income countries 19 17.9
High income countries 8 7.5
Educational level 
Less than high school diploma 24 22.6
High school diploma 30 28.3
University degree or higher 20 18.9
Missing 32 30.2
BMI
< 18.5 5 4.7
18.5-24.9 27 25.5
25-29.9 13 12.3
30-34.5 7 6.6
35+ 15 14.2
Missing 39 36.8
Parity (1 missing)
Nulliparae 55 52.4
Multiparae 50 47.6
ART
No 94 88.7
Yes 12 11.3
Multiple pregnancy
No 96 90.6
Yes 10 9.4
Pregnancy outcome
Abortion 12 11.3
Pregnancy 13 12.3
Delivery 80 75.5
Other pregnancy outcomes (ectopic 
pregnancy)
1 0.9
Mode of delivery
Vaginal delivery 19 23.8
spontaneous 14
forceps/vacuum 5
Cesarean section 61 76.3
emergent 30
urgent 17
  elective 14  
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first trimester and 20 during the third trimester of preg-
nancy or during the peripartum period. As for 13 haem-
orrhages, the mode of delivery was a CS while 7 cases 
followed a vaginal delivery. Fifteen out of 22 women 
died within one day from the end of pregnancy. Uterine 
atony was the main cause of bleeding (n = 11). After the 
complete review of the 22 deaths due to obstetric haem-
orrhage, 4 cases have been classified as unavoidable (1 
described as appropriate care, 3 as improvable care) and 
17 cases have been classified as avoidable with inappro-
priate quality of care. One case was not evaluable due to 
the lack of clinical documentation. The most frequent 
criticism reported by the professionals who assisted the 
women and by the auditors who assessed the haemor-
rhagic maternal deaths were: the lack of adequate com-
munication between professionals, the inability to ap-
preciate the severity of the clinical condition, the delay 
in diagnosis and treatment, the inappropriate care dur-
ing pregnancy and the inappropriate monitoring of ma-
ternal conditions after birth. The lack of an appropriate 
CS indication has been reported as a criticism in 15% of 
the deceased women who underwent a CS.
Genital tract sepsis was responsible for 18.3% (n = 11) 
of the direct deaths notified to the surveillance system, 
with 3 cases occurring post abortion during the first tri-
mester, 3 during the second trimester as a consequence 
of internal abortion leading to chorionamnionitis. The 
remaining 5 cases occurred during the third trimester 
of pregnancy, 1 after a vaginal delivery and 4 after a CS. 
The delay in diagnosis and treatment and the lack of 
adequate communication between professionals have 
been reported as the most frequent criticism.
Hypertensive disorders of pregnancy were responsible 
for 15.5% (n = 9) of the direct deaths, 4 of whom by 
preeclampsia, 3 eclampsia, and 2 HELLP syndrome 
cases. The most frequent criticism reported by the 
confidential enquiries was the delay in the treatment 
mainly related to the inappropriate use of Magnesium 
Sulfate and antihypertensive drugs. 
Indirect maternal deaths
Sepsis caused 12 indirect maternal deaths, 5 women 
died due to complications of H1N1 influenza, 4 cases 
were attributable to septic shock (2 congenital heart 
diseases, 1 leukaemia and 1 liquoral derivation) and 3 
cases were attributable to infectious diseases. All H1N1 
infections have been treated with antiviral therapy with-
in 48 hours from diagnosis. None of the women who 
died from complications of H1N1 influenza had been 
vaccinated during pregnancy: one died during the pu-
erperium and all the others during pregnancy between 
22 and 34 weeks of gestation. Among deaths notified 
as a consequence of infectious diseases, 1 woman died 
due to multi organ failure from malaria and 2 women 
have died as a consequence of a miliary tubercolosis in 
pregnancy. 
Cardiovascular disease was responsible for 9 cases: 4 
cardiomyopathies, 4 myocardial infarctions and 1 ar-
rhythmia. One death was assessed as avoidable. 
As for the 8 cases of indirect maternal mortality at-
tributed to spontaneous hemoperitoneum reviewers rec-
ommended to collect an accurate medical history of the 
pregnant women that includes any former diagnosis of 
endometriosis or symptoms and signs attributable to 
Ehlers-Danlos syndrome or similar diseases. The asses-
sors have also recommended a better knowledge of the 
pathognomonic signs of aortic dissection. 
Place of death and organization of care
The majority of maternal deaths occurred in hospital 
(90.5%), 47 in intensive care units, 39 in hospital wards, 
10 in surgery rooms and 1 in an emergency department. 
Six women were found dead at home, 2 died during an 
emergency transfer to reach a health service and one 
committed suicide out of the hospital. Most of mater-
nal deaths (66.7%) occurred in birth units attending ≥ 
1000 deliveries per year. Table 3 describes the organi-
zational characteristics of the facilities where maternal 
deaths have occurred. 
Avoidability of maternal deaths
Out of the 106 notified maternal deaths, 90 cases 
have been completely reviewed at the regional and na-
tional level. For 12 cases was not possible to assess the 
avoidability of maternal death, in 4 cases because of 
incomplete medical records. Three women were found 
Table 2
Causes of maternal deaths 
Direct causes of maternal death n. %
Obstetric haemorrhage 22 37.9
uterine atony 11
uterine rupture 2
abruptio placentae 2
genital lacerations 2
early pregnancy haemorrhage 2
uterine inversion 1
abnormally invasive placenta 1
unspecified haemorrhage 1
Genital tract sepsis 11 19.0
Hypertensive disorders of pregnancy 9 15.5
Amniotic fluid embolism 6 10.3
Thromboembolism 4 6.9
Cerebral haemorrhage 2 3.4
Other causes 4 6.9
Total 58
Indirect causes of maternal death n. %
Sepsis 9 23.1
Cardiovascular disease 9 23.1
Spontaneous haemoperitoneum 7 17.9
Neoplasm 5 12.8
Infectious diseases 3 7.7
Suicide* 3 7.7
Other causes 3 7.7
Total 39
*the information on psychiatric diagnosis was insufficient to support 
classification as direct death [10]
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dead at home for unknown causes and 5 were defined 
as sine materia cardiac deaths. Other 4 deaths have a 
pending post mortem report. 
Overall, the evaluation of 90 maternal deaths through 
confidential enquiries assessed 34 cases as unavoidable 
death with appropriate care, 15 as unavoidable with 
improvable care and 41 as avoidable due to inappropri-
ate care. Figure 2 describes the avoidability of maternal 
deaths notified by the ItOSS participating regions com-
pared to those reported by the United Kingdom mater-
nal surveillance system [5]. 
DISCUSSION
This is the first paper that describes the results of a 
maternal mortality surveillance adopting incident re-
porting and confidential enquiries of maternal deaths 
in Italy as well in southern Europe. This approach pro-
vides the detailed information on woman’s health status 
before and during pregnancy and on the circumstances 
of death, enabling to produce recommendations to 
avoid preventable deaths in the future. 
In accordance with previous ItOSS findings [10], 
maternal age ≥ 35 years and non-Italian citizenship are 
more frequent among deceased women (respectively 
50.5% and 25.5%) than in the background population 
of women giving birth in the participating Regions (35% 
and 20%) [12]. 
The proportion of direct deaths in our study is higher 
(59.8%) compared to UK figure (43.6%) in the period 
2014-2016 [5]. Therefore, an improvement in the qual-
ity of obstetric care is needed in Italy. Confidential en-
quiries were able to provide evidence of where the main 
problems in overcoming maternal mortality lie and an 
analysis of what can be done, highlighting the key areas 
requiring recommendations as well as guidelines for im-
proving clinical outcomes.
Thanks to the information made available by the 
ItOSS prospective surveillance, maternal sepsis is now 
recognised as a public health priority ranking as the first 
cause of direct and indirect maternal deaths jointly in 
Italy. Eight of 11 genital tract sepsis were defined as 
avoidable and the delay in diagnosis and treatment as 
well as the lack of adequate communication between 
professionals were reported as the most frequent criti-
cism. Considering the room for improvement high-
lighted by the assessment of confidential investigations, 
since 2017 the topic is part of an ongoing project on 
severe acute maternal morbidity coordinated by the 
ItOSS. Moreover, distance learning course on ma-
ternal sepsis has been offered to medical doctors and 
midwives in 2018 and Italy participated in the WHO 
Global Maternal Sepsis Study [13].
Since the results has highlighted the critical aspects 
of care associated to the high proportion of avoidable 
haemorrhagic maternal death (17/22), many concrete 
initiatives were taken from 2014 in order to dissemi-
nate results and promote a positive change. Three free 
distance learning courses on prevention, diagnosis 
and management of postpartum haemorrhage (PPH) 
have been offered by the ItOSS under the accredita-
tion system of Continuous Medical Education in order 
to address the health professionals training needs. In 
2014-2016 ItOSS implemented the first prospective 
population based Italian study on haemorrhagic severe 
acute maternal morbidity as part of the International 
Network Obstetric Survey System (INOSS) [14]. In 
2016 the first national guideline on PPH prevention 
and treatment promoted by ItOSS has been published 
by the Italian National Guidelines System [15]. 
The comparison between results obtained by prospec-
tive ItOSS surveillance and retrospective record-linkage 
procedure, raises interesting considerations. The differ-
ences in the reported causes of direct death and in their 
frequency distribution is worthy of attention. Maternal 
sepsis ranks as the first cause of death in the ItOSS 
maternal mortality surveillance and fourth in the vital 
statistics linkage procedures [10]. Maternal death from 
sepsis is increasing in countries with advanced health-
care systems [16] and vital statistics linkage procedures 
often misclassify this diagnosis [17]. Therefore, the abil-
ity of prospective surveillance to promptly identify the 
cases of sepsis is particularly valuable. Obstetric haem-
orrhage ranks first in the vital statistics linkage proce-
dures [10] and second and in the prospective ItOSS 
surveillance probably due to the recent increase of ma-
ternal sepsis incidence and due to the reduction of the 
Table 3
Organizational characteristics of the facilities where maternal 
deaths occurred
Structural requirements n %
Annual number of deliveries
< 1000 32 33.3
1000-1999 30 31.3
≥ 2000 34 35.4
Availability of flow charts on obstetric 
emergencies
82 85.4
Availability of blood centre 90 93.8
Availability of radiology reports within 1 hour 92 95.8
Availability of lab reports within 1 hour 96 100.0
Availability of intensive care unit 82 85.4
Availability of a surgery room devoted to 
emergency CS
91 94.8
CS = caesarean section
28
34,2
37,837,8
16,7
45,5
0
10
20
30
%
40
50
Unavoidable
death with
appropriate care
Unavoidable
death with
improvable care
Avoidable
death with
inappropriate care
UKOSS 2014-16 ItOSS 2013-17
Figure 2
Avoidability of maternal deaths assessed by the UKOSS and 
the ItOSS maternal mortality surveillance system.
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haemorrhagic deaths in the country [10]. Among indi-
rect maternal deaths, cardiovascular diseases match as 
the first cause in the results of both of the methods [10]. 
ItOSS is planning a collaboration with the cardiologists 
to promote the diagnostic capacity of clinicians who as-
sist pregnant and postpartum women and to facilitate a 
multidisciplinary management of these complex clinical 
conditions which, also due to the advanced maternal 
age at birth, occur more frequently to the observation 
of health professionals. 
Deaths caused by influenza H1N1 and deaths oc-
curred among women who underwent ART treatments 
are detected only by prospective maternal mortality 
surveillance. In the face of national and international 
recommendation to vaccinate pregnant women during 
seasonal influenza epidemic [18, 19], in Italy coverage 
is still very low. It is urgent to design and implement 
a proper information campaign to inform pregnant 
women that during the period of seasonal influenza 
epidemic, is highly recommended vaccination, frequent 
and thorough hand-washing and timely consultation of a 
doctor in case of fever and worsening dyspnoea [19, 20].
The specific MMR for neoplasm estimated retrospec-
tively by ItOSS is 0.8 maternal deaths per 100 000 live 
births [10] and the prospective surveillance identified 
5 cases of pregnancy associated malignancies during 
the years 2013-2017 in the participating regions (Table 
3). Cancers and pregnancy are two events increasingly 
associated probably due to the higher maternal age at 
conception and due to improved antenatal diagnosis 
opportunities. Reported incidence of pregnancies-asso-
ciated cancers is around 1/1000 in the literature [21], 
while a national figure is still lacking in Italy [22]. In 
2019 the ItOSS promoted an ongoing study with the 
collaboration of 18 Cancers Registries covering 25% 
of the national population, and the Italian Society of 
Obstetrics and Gynaecology (SIGO). Objective of the 
study is to estimate through record linkage procedures, 
the incidence of pregnancies and their outcomes in a 
wide cohort of women of reproductive age with neo-
plasm diagnosis. The results of the project will describe 
the occurrence of cancers during pregnancy and investi-
gate the relation between disease stadium and maternal 
and foetal outcomes. 
Obesity seems to play a role in the chain of events 
that can lead to serious maternal morbidity and mor-
tality. The proportion of obese women is respectively 
20% among the ItOSS notified maternal deaths and 7% 
among women of reproductive age resident in the same 
Italian Regions during the exact study period (www.
epicentro.iss.it/Passi/). This finding is in line with what 
has been found by the UK maternal mortality surveil-
lance system [23] confirming the urgency of supporting 
women’s ability to undertake pregnancy with an appro-
priate body weight. 
Among the 12 maternal deaths occurred in women 
undergoing ART, 4 women were aged > 42 years and 7 
had a BMI > 30, characteristics likely related to worst 
obstetric outcomes. Despite live births rates after ART 
treatments in UK are quite similar to those observed 
in Italy [23] the proportion of maternal deaths in this 
specific population is lower in UK (3.1%) [24] com-
pared to that found in the 8 Italian participating regions 
(11.3%). These results suggest that more attention 
should be payed to the selection of women accessing to 
ART treatment in the Italian National Health Service 
in order to make ART a safe choice for the women. In 
this respect, women older than 42 years or with BMI > 
30 cannot access to high level NHS ART treatments in 
England, as recommended by NICE [25].
Prospective maternal mortality surveillance through 
incident reporting and confidential enquiries confirms 
itself as a better approach than vital statistic system to 
identify the current incidence of the specific causes of 
maternal deaths and current priorities for action. On 
the other hand, due to the low incidence of maternal 
deaths in Italy, the large retrospective time span of vital 
statistics analysis provides a sufficient number of cases 
to take into account MMR differences by geographi-
cal area and by women’s characteristics [9, 10]. The 
MMR estimated through the prospective surveillance 
(7.56/100 000 live births) is not significantly lower (p 
value = 0.08) than the MMR of 9.18/100 000 live births 
estimated through the record-linkage procedures in 
seven years, from 2006 to 2012 [10]. 
To date, the main limits of the ItOSS surveillance are 
the subnational coverage and its recent start, which lim-
its the robustness of the data analysis. Moreover, the 
delayed availability of post mortem reports in case of 
judicial authority involvement impairs the possibility of 
a timely assessment of all cases. Short term perspectives 
include the extension of the surveillance to the whole 
country, in 2019 a 91% coverage of national newborn 
being reached. A pilot project of  perinatal mortality 
surveillance [26], further prospective population-based 
studies on severe acute maternal morbidity, the con-
tinuous training of health professionals in the critical 
areas that arise from the surveillance and the provision 
of recommendations for clinical practice are ongoing 
activities coordinated by ItOSS in the field of maternal 
and newborn health.
CONCLUSION
A dual approach to investigate and monitor mater-
nal mortality including vital statistics analysis and pro-
spective surveillance relaying on incident reporting and 
confidential enquiries is, in our opinion, the best option 
for case ascertainment. Learning lessons and acting on 
the results is the core of using an active surveillance ap-
proach aimed at saving more women’s lives and at im-
proving quality of maternity service. Confirming the va-
lidity of this dual approach the last Euro Peristat Report 
[27] described the ItOSS as one of the 7 enhanced ma-
ternal mortality surveillance systems active in Europe. 
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